The FDA has approved Ozempic (semaglutide) to reduce the risk of kidney disease worsening and cardiovascular death in those with T2D and CKD.
With thousands of press releases published each week, it can be difficult to keep up with everything on . To help healthcare ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback